Paper36934611
DDTC-Cu(I) based metal-organic framework (MOF) for targeted melanoma therapy by inducing SLC7A11/GPX4-mediated ferroptosis.
Li C and 10 others. Colloids Surf B Biointerfaces, 2023. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. DDTC-Cu(I) based metal-organic framework (MOF) for targeted melanoma therapy by inducing SLC7A11/GPX4-mediated ferroptosis. Papers, record 36934611. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36934611
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- DDTC-Cu(I) based metal-organic framework (MOF) for targeted melanoma therapy by inducing SLC7A11/GPX4-mediated ferroptosis.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Metal-Organic Frameworks | Major topic |
| Ferroptosis | Major topic |
| Alcoholism | Major topic |
| Substance Withdrawal Syndrome | Major topic |
| Melanoma | Major topic |
| Animals | |
| Humans | |
| Ditiocarb | |
| Disulfiram | |
| Copper | |
| Cell Line, Tumor | |
| Amino Acid Transport System y+ |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42514865 | Copper Complexes: Emerging Micro- and Nanosystems for Dermatological Treatment. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514865 | PubMed |
| 42405084 | Copper-based metal-organic frameworks: applications and prospects in cancer diagnosis and therapy. | RSC Adv | 2026 | https://conductscience.org/library/papers/42405084 | PubMed |
| 42402086 | Recent advances in metal-organic frameworks for the diagnosis and treatment of breast cancer. | Discov Nano | 2026 | https://conductscience.org/library/papers/42402086 | PubMed |
| 42058920 | Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence. | iScience | 2026 | https://conductscience.org/library/papers/42058920 | PubMed |
| 41424843 | Cuproptosis-triggering nanomedicine boosts antitumor immunotherapy. | Theranostics | 2026 | https://conductscience.org/library/papers/41424843 | PubMed |
| 40873681 | Application of Metal-Organic Frameworks Nanoparticles in the Diagnosis and Treatment of Breast Cancer. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40873681 | PubMed |
| 40545912 | Antitumoral Efficacy of AuNRs-Laden ECFCs In Vitro and In Vivo: Decoding the Heat and Rays Combo Treatment in Breast Cancer and Melanoma Cells. | Adv Healthc Mater | 2025 | https://conductscience.org/library/papers/40545912 | PubMed |
| 40380264 | Decreased serum and local GPX4 and SLC7A11 expression correlates with disease severity in non-traumatic osteonecrosis of the femoral head. | J Orthop Surg Res | 2025 | https://conductscience.org/library/papers/40380264 | PubMed |
| 40200790 | The Regulation of Trace Metal Elements in Cancer Ferroptosis. | Adv Biol (Weinh) | 2025 | https://conductscience.org/library/papers/40200790 | PubMed |
| 40089774 | Functional nanozyme system for synergistic tumor immunotherapy via cuproptosis and ferroptosis activation. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40089774 | PubMed |
| 40042663 | Metabolomic analysis to study the effect of foliar copper supplementation on sulfur-containing compounds of garlic bulb by LC-MS. | Metabolomics | 2025 | https://conductscience.org/library/papers/40042663 | PubMed |
| 39987136 | Copper-based metal-organic frameworks for antitumor application. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/39987136 | PubMed |
| 39474127 | Recent advances in copper homeostasis-involved tumor theranostics. | Asian J Pharm Sci | 2024 | https://conductscience.org/library/papers/39474127 | PubMed |
| 39323342 | Disulfiram-Copper Potentiates Anticancer Efficacy of Standard Chemotherapy Drugs in Bladder Cancer Animal Model through ROS-Autophagy-Ferroptosis Signalling Cascade. | Curr Cancer Drug Targets | 2025 | https://conductscience.org/library/papers/39323342 | PubMed |
| 38918694 | Cuproptosis in cancer: biological implications and therapeutic opportunities. | Cell Mol Biol Lett | 2024 | https://conductscience.org/library/papers/38918694 | PubMed |
| 38511140 | Ferroptosis in hepatocellular carcinoma, from mechanism to effect. | Front Oncol | 2024 | https://conductscience.org/library/papers/38511140 | PubMed |
| 37903946 | ROS-producing nanomaterial engineered from Cu(I) complexes with P2N2-ligands for cancer cells treating. | Discov Nano | 2023 | https://conductscience.org/library/papers/37903946 | PubMed |
| 37795022 | Ferroptosis as a promising therapeutic strategy for melanoma. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37795022 | PubMed |
| 37767404 | Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37767404 | PubMed |
| 37373523 | Harnessing the Potential of Non-Apoptotic Cell Death Processes in the Treatment of Drug-Resistant Melanoma. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37373523 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GPX4 | 2879 | PubTator's text mining | https://conductscience.org/library/genes/2879 | NCBI Gene |
| SLC7A11 | 23657 | PubTator's text mining | https://conductscience.org/library/genes/23657 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36934611
GET https://conductscience.org/api/papers/v1/36934611/cited_by?page=2